PROSPECT - Profiling of Resistance Patterns & Oncogenic Signaling Pathways in Evaluation of Cancers of the Thorax and Therapeutic Target Identification

Recruiting

Cancer ProfilingPROSPECT - Profiling of Resistance Patterns & Oncogenic Signaling Pathways in Evaluation of Cancers of the Thorax and Therapeutic Target Identification

Sponsor:

M.D. Anderson Cancer Center

Code:

NCT05049837

Conditions

Lung Cancer

Cancer of Thorax

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Group Specific Aim 1

Group Specific Aim 2

Group Specific Aim 3

Group Specific Aim 4

Group Specific Aim 5

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-19. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2025-02-03.